These observations are consistent with the clinical literature and motivated us to further examine the roles of SDF1α/CXCR4 inhibition with RT in vitro and then in vivo using orthotopic primary and bone metastatic PCa models in mice. The gene discussed is CXCR4; the disease is posterior cortical atrophy.